Catalyst Wire Dossier Catalyst Wire Dossier

Nenocorilant

nenocorilant · Corcept Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nenocorilant, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

See pricing